top of page

MethylDetox Profile

More than 50% of people are affected by genetic mutations in the methylation pathway.

​

Methylation can play an important role in many chronic diseases. By understanding your genetics you can prevent and address these conditions with the right nutrition.

​

The MethylDetox Profile tests critical genes in the methylation pathway. The methylation pathway is the major part of detoxification and the metabolic cycle. Based on your genetics, this profile enables you to address many important chronic medical conditions by using nutrition and nutrient supplementation.

​

Comprehensive testing for methylation and detoxification

 

The MethylDetox Profile gives more actionable information than MTHFR testing alone, giving you a more complete picture of your body’s methylation and detoxification. The MethylDetox profile includes Smart Commentaries, detailing recommended nutrients based on your genetics.

​

Standard MTHFR genotyping only evaluates folic acid metabolism. Scientific research reveals that a variety of genes are involved in maintaining methionine/homocysteine balance. Genetic variations (SNPs) in these important genes influence your methylation potential. Individual methylation is monitored using homocysteine levels. Important SNPs are included to evaluate your ability to methylate neurotransmitters, DNA and toxins.

Test results

Test results include Smart Commentaries created by clinicians and scientists. Smart Commentaries include personalized recommendations for diet and nutrition supplementation.

Who may benefit from this test?

 

Individuals with any of the following diagnoses or symptoms, lab data indicating the tendency toward:

  • Cardiovascular Diseases e.g. hypertension, coronary artery disease, stroke 4-10

  • Neurological Disorders e.g. depression, dementia, Alzheimer’s disease, ADD/ADHD, ASD, chronic fatigue syndrome, migraine, insomnia 7, 10-17

  • Metabolic Conditions e.g. metabolic syndrome, diabetes mellitus, kidney diseases, reduced ability to metabolize medications, multiple chemical sensitivity 10, 18-21

  • Musculoskeletal Disorders e.g. osteoporosis 10, 22

  • Eye Diseases e.g. macular degeneration 23, 24

  • Cancer e.g. colorectal, breast, and others 1, 10, 25

      Dr. Steve Alukonis DC, DABCO    

**NEW OFFICE LOCATION**

 Merritt Island Office

 2235 North Courtenay Pkwy Suite 4A

Merritt Island FL, 32952

321-425-2519  FAX 321-425-2523

stevealukonis@bellsouth.net

bottom of page